TPP Pharma Market Research: ARCH Model Clinical Planning

The pharmaceutical industry faces challenges with traditional target product profile approaches in clinical development planning. TPP pharma methodologies often lack integration across R&D functions, leading to costly misalignments between clinical trials and market requirements. The ARCH model—covering Approval, Reimbursement, Commercial viability, and Hope—offers a comprehensive framework for TPP market research that replaces single-point predictions with scenario-based planning. For more info: https://www.zs.com/insights/tpp-pharma-clinical-development-planning-arch-model